Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Seven-day Repeated Dose Clinical Pharmacological Study of FYU-981 Administered to Hyperuricemia

NCT02837198 is registered in ClinicalTrials.gov with Fuji Yakuhin Co., Ltd. as lead sponsor.

NCT NCT02837198
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02837198 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Seven-day Repeated Dose Clinical Pharmacological Study of FYU-981 Administered to Hyperuricemia
Lead sponsor
Fuji Yakuhin Co., Ltd.
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2016
Completion date
March 31, 2018
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperuricemia